Cassian Yee

This inventor holds 11 USPTO granted patents and 21 published patent applications and 3 EPO patents. Top assignee: The University of Texas System. Active years: 2023-2026.

USPTO Granted Patents = 11 (Patent Applications = 21)

% Patents Active = 63.6

EPO Patents = 3 (Patent Applications = 28)

Average Co-Inventor Count = 2.0

ph-index = 1

Company Filing History:

11 out of 5,627

The University of Texas System

patents

Years Active: 2023-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12742002 - ENGINEERED T CELL RECEPTORS AND METHODS OF USE (2026-09-22),

2. 12735470 - ENGINEERED T CELL RECEPTORS AND METHODS OF USE (2026-09-15),

3. 12673980 - ENGINEERED T CELL RECEPTORS AND METHODS OF USE (2026-07-07),

4. 12637511 - METHODS FOR EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF (2026-05-26),

5. 12552851 - T CELL RECEPTORS WITH VGLL1 SPECIFICITY AND USES THEREOF (2026-02-17),

6. 12319740 - Methods for production of tissue resident memory-like T cells and use thereof (2025-06-03),

7. 12202877 - T cell receptors with mage-B2 specificity and uses thereof (2025-01-21),

8. 12178787 - T cell receptors for immunotherapy (2024-12-31),

9. 12173317 - Use of histone modifiers to reprogram effector T cells (2024-12-24),

10. 11696933 - HLA-restricted VCX/Y peptides and T cell receptors and use thereof (2023-07-11),

11. 11684657 - HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject (2023-06-27),

Title: Cassian Yee: Innovator in T Cell Therapy

Introduction

Cassian Yee is a prominent inventor based in Houston, TX (US), known for his significant contributions to the field of immunotherapy. With a total of 11 patents, he has made remarkable strides in the production and application of T cells for cancer treatment.

Latest Patents

Yee's latest patents include innovative methods for the production of tissue resident memory-like T cells. These methods utilize a combination of hypoxia and TGFβ to enhance the efficacy of T cell therapies. Additionally, he has developed techniques for generating T cell receptors with MAGE-B2 specificity, which are crucial for targeting cancer cells. These advancements provide new avenues for adoptive cell therapy, offering hope for improved cancer treatments.

Career Highlights

Cassian Yee is affiliated with the University of Texas System, where he conducts groundbreaking research in the field of immunology. His work focuses on harnessing the power of T cells to combat cancer, making him a key figure in the ongoing fight against this disease.

Collaborations

Yee collaborates with esteemed colleagues such as Ke Pan and Gregory Lizée, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Cassian Yee's innovative work in T cell therapy exemplifies the potential of scientific research to transform cancer treatment. His contributions continue to pave the way for advancements in immunotherapy, making a significant impact in the medical field.